Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innvocept Global Solutions is a private, technology-led clinical research organization and healthcare consulting company focused on end-to-end research and clinical development services for pharmaceutical, biotechnology, and medical device clients. The company supports regulated clinical studies, especially Phase II-IV trials and real-world evidence studies, and offers clinical operations, regulatory support, data management, biostatistics, medical writing, pharmacovigilance, and market research services. Innvocept positions itself as a service provider rather than a therapeutic product developer, with capabilities spanning study design, site selection, patient recruitment, and digital clinical systems. Its footprint includes entities and offices in India, the United States, Canada, and Malaysia, serving clients across multiple geographies. Overall, Innvocept appears to be a small, active CRO focused on outsourced clinical development and healthcare analytics rather than proprietary drug pipeline creation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innvocept Global Solutions.